| Eye Site Of Lima | |
|
1034 W Market St, Lima, OH 45805-2730 | |
| (419) 228-8116 | |
| (419) 228-1160 |
| Full Name | Eye Site Of Lima |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1034 W Market St, Lima, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295008282 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Eye Site Of Lima 1034 W Market St, Lima, OH 45805-2730 Ph: (419) 228-8116 | Eye Site Of Lima 1034 W Market St, Lima, OH 45805-2730 Ph: (419) 228-8116 |
News Archive
The Center for Health Program Management, and funding partners Sierra Health Foundation, The California Endowment and The California Wellness Foundation announced that $1.6 million in grant funding has been awarded to four counties to implement an innovative approach to juvenile justice reform known as the Positive Youth Justice Initiative.
Doctors could improve the care of high blood pressure by relying more on home blood pressure checks and not so much on the less-accurate office BP assessments, wrote health care quality experts from The University of Texas Health Science Center at Houston in an editorial in the journal JAMA.
Genzyme Corporation announced data from its CAM314 randomized Phase 3 clinical trial comparing Campath (alemtuzumab) in combination with Fludara (fludarabine phosphate) (FluCAM) to Fludara alone in patients with relapsed and refractory chronic lymphocytic leukemia (CLL) demonstrated that the FluCAM regimen significantly reduced the risk of disease progression or death compared to single-agent Fludara.
Researchers involved in the phase II NRG Oncology RTOG 0526 trial studying low dose rate (LDR) prostate brachytherapy (BT) following local recurrence (LR) after external beam radiotherapy (EBRT) for patients with low-to-intermediate risk prostate cancer reported late Grade 3 gastrointestinal and genitourinary adverse events (AEs) occurring in 14% of trial participants.
Researchers at Oregon Health & Science University have discovered that blocking a certain enzyme in the brain can help repair the brain damage associated with multiple sclerosis and a range of other neurological disorders.
› Verified 4 days ago
Dr. Christa Heckman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2765 Fort Amanda Rd, Suite 100, Lima, OH 45805 Phone: 419-228-3937 Fax: 419-882-3939 | |
Speelman Eye Care, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2155 Allentown Rd, Lima, OH 45805 Phone: 419-228-3800 | |
Richard E Cheney, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1593 Allentown Rd, Lima, OH 45805 Phone: 419-228-9176 | |
Stephen N. Cajacob, O.d. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1034 W Market St, Lima, OH 45805 Phone: 419-228-8116 Fax: 419-228-1160 | |
Vision Center Of Lima, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1593 Allentown Rd, Lima, OH 45805 Phone: 419-228-9176 Fax: 419-228-9535 | |
Michael F Williams Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2155 Allentown Rd, Lima, OH 45805 Phone: 419-228-3800 | |
Omar Amjad Sweidan, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2155 Allentown Rd, Lima, OH 45805 Phone: 419-228-3800 |